Insulin Aspart Injection: Clinical Trials

3 trials of Insulin Aspart Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Recruiting 1
Phase 31Completed 1

Follow Insulin Aspart Injection: new trials by email Literature Review of Insulin Aspart Injection trials Research Report on Insulin Aspart Injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin Aspart
GZR101 80 Injection, GZR33 Injection, Insulin Aspart Injection - Healthy Participants
Phase 1RecruitingGan & Lee Pharmaceuticals.262026-11-022026-11-17
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM
Insulin Degludec and Insulin Aspart Injection, Insulin Aspart Injection - Type 2 Diabetes Mellitus
Not applicableCompletedBeijing Hospital2182023-03-232025-12-03
A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety
insulin Aspart injection, insulin Aspart injection (NovoRapid) - Diabetes
Phase 3CompletedTonghua Dongbao Pharmaceutical Co.,Ltd5632015-06-192023-12-22

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

Beijing Hospital (1)  ·  Gan & Lee Pharmaceuticals. (1)  ·  Tonghua Dongbao Pharmaceutical Co.,Ltd (1)

Countries

China (3)

Top investigators

WP Jia (1)